Researchers at the National Cancer Institute are recruiting patients with recurrent chordoma for a clinical trial of a therapeutic vaccine that harnesses the immune system to kill tumor cells.

Resources from the 2013 Community Conference are now available on our website. Check out presenter slides, handouts, participant materials and photos.

Check out the research progress we’ve made since the Chordoma Foundation was started in 2007. In just a few years, we’ve funded and facilitated programs to accelerate chordoma research, which informs cancer research overall.

Having chordoma makes us one in a million. But what’s more uncommon than our disease? Our determination to beat it.